SCHEMBL29486146

SCHEMBL29486146

CC(C)CCNC(=O)c1cccc(Nc2ccc(C(=O)O)cc2C2CC2)c1C1CC1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ RAB9A P51151 3/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ CREBBP Q92793 1/20 0.40
▸ F3 P13726 1/20 0.40
▸ KCNA5 P22460 6/20 0.39
▸ GPR52 Q9Y2T5 1/20 0.39
▸ KMT2A Q03164 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ HPGD P15428 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ TBXA2R P21731 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28746344 1.00 SMN1; SMN2 (0.41) SMN1; SMN2RAB9ANPC1CREBBPF3
SCHEMBL30666298 0.91 GAA (0.39) SMN1; SMN2RAB9ANPC1F3KCNA5
SCHEMBL29615863 0.91 GAA (0.39) SMN1; SMN2RAB9ANPC1F3KCNA5
SCHEMBL28746342 0.91 GAA (0.39) SMN1; SMN2RAB9ANPC1F3KCNA5
SCHEMBL29486081 0.85 GPR52 (0.36) SMN1; SMN2RAB9ANPC1F3KCNA5
SCHEMBL22899346 0.85 GPR52 (0.36) SMN1; SMN2RAB9ANPC1F3KCNA5
SCHEMBL21617101 0.78 KMT2A (0.43) SMN1; SMN2RAB9ANPC1F3KCNA5
SCHEMBL31611960 0.78 KMT2A (0.43) SMN1; SMN2RAB9ANPC1F3KCNA5
SCHEMBL22899612 0.77 SMN1; SMN2 (0.38) SMN1; SMN2RAB9ANPC1F3KCNA5
SCHEMBL29486220 0.77 SMN1; SMN2 (0.38) SMN1; SMN2RAB9ANPC1F3KCNA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114423741-B aryl-N-aryl derivatives for the treatment of RNA viral infections ABIVAX公司 2023-11-07 — — CN disclosed
EP-3999493-A1 ARYL-N-ARYL DERIVATIVES FOR TREATING A RNA VIRUS INFECTION ABIVAX (FR) 2022-05-25 — — EP disclosed
CN-114423741-A aryl-N-aryl derivatives for the treatment of RNA viral infections ABIVAX公司 2022-04-29 — — CN disclosed
Send feedback